UBXN11 and glioblastoma: Since P-AscH− significantly improves the response to SOC and induced DNA damage in mesenchymal GBM cells in vitro, we postulated that P-AscH− could enhance SOC therapy in vivo and that the frequency of P-AscH− dosing played a crucial role in response.